Letter re: Neurologists and the economics of MS treatment: Lighting candles, not cursing the darkness

In their editorial, Drs. Bourdette and Whitham1 mentioned "avoiding use of repository corticotropin (Acthar gel) to treat MS relapses." Objectively considering H.P. Acthar Gel, the only Food and Drug Administration–approved noncorticosteroid therapy option for multiple sclerosis (MS) relapse, as a treatment option is in the best interest of patients.
Source: Neurology - Category: Neurology Authors: Tags: WRITECLICK & amp;reg; EDITOR ' S CHOICE Source Type: research